The pharmacology of tardive dyskinesias.
D001479:Basal Ganglia / Q000187:drug effects / Q000378:metabolism; D001480:Basal Ganglia Diseases / Q000139:chemically induced / Q000378:metabolism; D001923:Brain Chemistry / Q000187:drug effects; D004298:Dopamine / Q000378:metabolism / Q000494:pharmacology*; D006801:Humans; D006816:Huntington Disease / Q000378:metabolism; D001523:Mental Disorders / Q000188:drug therapy; D009069:Movement Disorders / Q000378:metabolism*; D009474:Neurons / Q000187:drug effects; D010276:Parasympatholytics / Q000494:pharmacology; D010300:Parkinson Disease / Q000378:metabolism; D011955:Receptors, Drug / Q000187:drug effects; D014149:Tranquilizing Agents / Q000009:adverse effects
D010276:Parasympatholytics; D011955:Receptors, Drug; D014149:Tranquilizing Agents; D004298:Dopamine